Peptide therapy TikTok claims: what the science actually supports

What did @lindsay_perry actually say?

Lindsay described selank as a "Russian peptide" that helps with "memory, attention, calming neurotransmitters" and "overall anxiety." She also claimed it increases BDNF, which she correctly identified as a protein that supports neurons and "the growth of new neurons." On a practical note, she flagged that selank comes as a nasal spray, positioning it as a needle-free alternative for people who want to try peptides without injecting.

She also acknowledged cost as a real barrier, noting the bottle doesn't last long if you use it daily. No dosing claims, no disease cure claims. Pretty restrained for TikTok peptide content, honestly.

Does the science back this up?

The short answer: partially, and mostly in animal models. The human data is thin, mostly from Russian clinical literature that hasn't been independently replicated in large Western trials. That matters more than most selank promoters admit.

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin. Russian researchers at the Institute of Molecular Genetics developed it in the 1990s, and early clinical studies conducted in Russia did suggest anxiolytic effects. Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) reported reduced anxiety and improved cognitive function in patients with anxiety-asthenic disorders. However, the trial sizes were small and the methodology wouldn't pass muster in a typical FDA submission.

On BDNF: Inozemtseva et al. (2008, Doklady Biological Sciences) found selank modulated BDNF expression in rat brain tissue, which is consistent with Lindsay's claim. But modulating BDNF expression in a rat hippocampus and "growing new neurons" in a human brain are not the same sentence.

What did they get wrong (or right)?

She got the mechanism framing mostly right. Selank does appear to influence the GABAergic system, which is the primary calming neurotransmitter system, and the enkephalinase inhibition pathway, which affects anxiety-related signaling. Saying it helps with "calming neurotransmitters" is a reasonable lay summary, not misinformation.

What's missing: she described it as helping to "clear" neurotransmitters, which is vague enough to be confusing. Selank's mechanism isn't primarily about clearing transmitters. It's more accurately about modulating breakdown of enkephalins and influencing GABA receptor sensitivity. The word "clearing" could mislead people into thinking it works like a stimulant or detox product.

The BDNF claim is accurate as far as it goes, but the leap from "increases BDNF" to cognitive enhancement in healthy humans is not supported by current evidence. BDNF is genuinely important for neuroplasticity, but oral and even nasal administration of peptides faces significant bioavailability questions that Lindsay didn't mention at all.

• The "Russian peptide" framing is accurate and worth noting because it explains why the research base is narrow and hard to verify independently.
• The nasal spray benefit claim is real. Intranasal delivery does bypass first-pass metabolism and may improve CNS delivery compared to oral routes.
• The cost acknowledgment is honest and useful.

What should you actually know?

Selank is not FDA-approved. In the United States, it's available through compounding pharmacies operating under specific regulatory frameworks, and that status can change. If you're considering it, the conversation has to start with a licensed provider who can evaluate whether it's appropriate for your specific situation, not a TikTok video.

The anxiety and cognitive research is real but limited. Cornélissen et al. and independent Western replications of the Russian clinical data simply don't exist yet in meaningful numbers. That's not a reason to dismiss the research, but it is a reason to be honest about the confidence level. "Promising in early research" is not the same as "clinically validated."

The nasal route matters. Intranasal peptide delivery has legitimate pharmacological rationale. Dhuria et al. (2010, Journal of Pharmaceutical Sciences) reviewed evidence that intranasal administration can deliver peptides to the CNS via the olfactory pathway, which does give selank's delivery format more credibility than, say, an oral capsule of the same compound.

If anxiety or cognitive issues are affecting your daily functioning, those are clinical symptoms that deserve a real clinical evaluation, not a peptide purchase from a research chemical supplier.